-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics
January 01, 2023 - Administration-approved medications for one of four common chronic conditions (diabetes, hypertension, insomnia, depression
-
effectivehealthcare.ahrq.gov/sites/default/files/data-extraction.ppt
January 01, 2009 - Tables: Example (I)
Evidence Tables: Example (I)
These drafts of tables on traumatic brain injury and depression
-
psnet.ahrq.gov/web-mm/intraosseous-line-extravasation-pediatric-trauma-patient
September 29, 2021 - WebM&M Cases
Fatal Patient-Controlled Analgesia (PCA) Opioid-Induced Respiratory Depression
-
digital.ahrq.gov/sites/default/files/docs/publication/r36hs020165-hirsch-final-report-2012.pdf
January 01, 2012 - So, if I saw you today for depression, for example, and you
happen to have diagnosis for diabetes for … refilled, even if we didn't talk
about it, diabetes is not the reason you're there, we are talking about depression
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-fullreport.pdf
April 01, 2018 - unfamiliarity with the
effective use of analgesics and fear of adverse effects, such as respiratory depression … be undertreated for pain out of concerns about
addiction or other adverse effects like respiratory depression
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
January 01, 2014 - disease and dyspepsia
• Pulmonary disease/asthma
• Arthritis and nontraumatic joint disorders
• Depression … waves on the electrocardiogram (ECG);
(c) ECG changes indicative of ischemia (ST segment elevation or depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
August 31, 2017 - results section and/or
the summaries seemed incomplete
(e.g., comorbid results excluded
mention of depression … Specifically, I was
surprised to see that patients with
various types of comorbidity (i.e.,
ADHD, autism, depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
March 16, 2017 - rates (both related to YMRS scores;
p values 0.5, 0.001, and 0.0001, respectively),
although not for depression … Only the 10 mg twice daily
group was favored over placebo for depression
scores on the CDRS.
-
effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
March 16, 2017 - rates (both related to YMRS scores;
p values 0.5, 0.001, and 0.0001, respectively),
although not for depression … Only the 10 mg twice daily
group was favored over placebo for depression
scores on the CDRS.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
February 01, 2013 - 4 4 †
How do psychosocial factors such as depression, socioeconomic status,
motivation/self-efficacy … 4 4 1 1 2
How do psychosocial factors such as depression, socioeconomic status,
motivation/self-efficacy … • Psychosocial factors: How do factors such as depression, socioeconomic status,
motivation/self-efficacy … o How do psychosocial factors such as depression, socioeconomic status, motivation/self-
efficacy, fear-avoidance
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - ,
Pfizer provided the data, and the subsequent IQWiG review reported no benefit of reboxetine for
depression … Selective serotonin reuptake inhibitors in
childhood depression: systematic review of
published versus … Reboxetine for acute treatment of major
depression: systematic review and meta-analysis
of published … Health Condition(s)
or Problem(s)
Studied
Primary health condition(s) or problem(s) studied (e.g., depression
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - TEP Reviewer
#1
It might be noted that for many trials of
psychological therapies, scores on
depression … measures were very low at
baseline, beneath thresholds for clinically
meaningful depression, thus … revised the Applicability
section to note that most trials of
antidepressants excluded patients
with depression … or only enrolled a
small proportion with depression,
so that it is not clear if there would
be additional
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/gestational-diabetes-screening
August 10, 2021 - No significant differences were found in anxiety and depressive symptoms before and after screening for … that undergoing screening or receiving a false-positive result may not be associated with anxiety or depression … intentions before delivery
Low for no association between undergoing screening and anxiety and depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
January 01, 2019 - thrombocytopenia: a cost-effectiveness analysis
2007 Pharmacoeconomics
20028779 Screening for postnatal depression … the cost-
effectiveness of CT colonography
2009 Radiology
19624978 Methods to identify postnatal depression … of Group Cognitive Behavioral
Therapy Compared with Routine Primary Care for Women
with Postnatal Depression
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
June 09, 2020 - of naltrexone vs placebo or no naltrexone on health outcomes (eg, global function, quality of life, depression … medications for opioid use disorder on health outcomes (eg, such as global function, quality of life, depression … Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
June 20, 2017 - outcomes (eg, reduced orthopedic pain, sleep apnea, or asthma; improved quality of life, functioning, or depression … the 3 trials not shown in Figure 3 because of insufficient data. 23 , 62 , 63 Similarly, measures of depression … One trial reported no differences in percentage screening positive for depression.
-
effectivehealthcare.ahrq.gov/products/back-pain-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quality-gap-palliative-hospice_research-protocol.pdf
June 27, 2011 - Outcomes related to
families and caregivers of these patients (e.g., depressive symptoms of family
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs022955-thompson-final-report-2020.pdf
January 01, 2020 - second primary cancer as well as substantially higher rates of some mental disorders, such as depression … Management of cancer symptoms: pain, depression, and fatigue.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallspxspecs.pdf
February 01, 2018 - Note: In the report, ADL = activities of daily living; BMI = body mass index; Depression Score:
0-9 … Toileting Repeat as above for mobility.
12
Column Header Source Valid Input Rule/Display
4 Depression